- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Cobicistat + elvitegravir + emtricitabine + tenofovir – March 2013
Cobicistat + elvitegravir + emtricitabine + tenofovir, tablet, cobicistat 150 mg, elvitegravir 150 mg, emtricitabine 200 mg, tenofovir 300 mg, Stribild®
Last updated
8 November 2023